Seppo W. Langer

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

Staffan Welin, Seppo W. Langer, Lene Weber Vestermark et al. · Annals of Oncology · 2012 · 1K citations

Prognostic Factors, Glioma, Gastrointestinal Oncology +10

Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study

Fiona Blackhall, Kevin Jao, Laurent Greillier et al. · Journal of Thoracic Oncology · 2021 · 239 citations · Full text

Head-to-Head Comparison of ⁶⁴Cu-DOTATATE and ⁶⁸Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors

Camilla Bardram Johnbeck, Ulrich Knigge, Annika Loft et al. · Journal of Nuclear Medicine · 2016 · 226 citations · Full text

A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis

Barbara Malene Fischer, Jann Mortensen, Seppo W. Langer et al. · Annals of Oncology · 2006 · 172 citations · Full text

Positron Emission Tomography, Bone Marrow Analysis, Oncologic Imaging +13

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies

H.T. Mouridsen, Seppo W. Langer, Jan Buter et al. · Annals of Oncology · 2006 · 159 citations · Full text

Pharmacology, Pharmacotherapy, Medicine +1